clinician-mediated JASPER for Autism Spectrum Disorder
This trial will study whether JASPER, a play-based intervention, is effective in treating children with autism spectrum disorder. The trial will last 3 years, recruiting 90 participants (10 per site per year) from Boston University, UCLA, and Weill Cornell. The participants will be randomized to receive JASPER from either a clinician or their caregiver, and after 10 weeks, will be evaluated to see if they respond to the treatment. Nonresponders will then receive a mix of clinician and caregiver-facilitated JASPER, while responders will continue to receive the same treatment for an additional 10 weeks. The outcome of
- Autism Spectrum Disorder
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
How many individuals have been selected to take part in this research initiative?
"To fulfill the trial requirements, 90 individuals who meet all of the eligibility criteria must participate. The Semel Institute in Boston and BU White Plains are two medical centers which currently offer this clinical trial."
Does this research still have vacancies open to the public?
"According to the clinicaltrials.gov documents, enrollment is still open for this trial that was first advertised on 27th April 2021 and last modified on 2nd September 2022."
Does this research endeavor include elderly individuals as participants?
"This experiment is seeking to enrol participants aged between 18 months and 5 years."
What criteria must potential participants fulfill in order to join this experiment?
"This trial is seeking 90 participants that are between 18 months and 5 years old, diagnosed with autism spectrum disorder."